SEC Filings for Ligand Pharmaceuticals Incorporated (LGND)

$ 115.72   -2.21 (-1.87%) Volume: 97.98k 3:04 PM EDT 5-Aug-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities102/18/2020
4Statement of changes in beneficial ownership of securities102/18/2020
SC 13GStatement of acquisition of beneficial ownership by individuals102/14/2020
3Initial statement of beneficial ownership of securities102/14/2020
SC 13GStatement of acquisition of beneficial ownership by individuals102/14/2020
SC 13GStatement of acquisition of beneficial ownership by individuals702/14/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/13/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals502/12/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals502/12/2020
8-KCurrent report pursuant to Section 13 or 15(d)802/11/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals102/10/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals502/10/2020
8-KCurrent report pursuant to Section 13 or 15(d)1602/06/2020
8-KCurrent report pursuant to Section 13 or 15(d)301/10/2020
SC 13GStatement of acquisition of beneficial ownership by individuals101/10/2020
123456789101112131415